2.3 Dysrhythmias, Cardiac Arrest, and ACLS
Key Takeaways
- VF and pulseless VT are shockable: defibrillate at 200 J biphasic, resume CPR immediately, give epinephrine 1 mg every 3-5 minutes, and amiodarone 300 mg after the third shock.
- Asystole and PEA are non-shockable: high-quality CPR plus epinephrine 1 mg every 3-5 minutes while treating reversible causes (the Hs and Ts).
- Stable narrow-complex SVT is treated with vagal maneuvers, then adenosine 6 mg rapid IV push followed by 12 mg; unstable tachycardia gets synchronized cardioversion.
- Symptomatic bradycardia is treated with atropine 1 mg IV (max 3 mg) per 2020 AHA guidance, then transcutaneous pacing or a dopamine or epinephrine infusion.
Cardiac Arrest: Shockable vs Non-Shockable
The ACLS arrest algorithms split on one question: is the rhythm shockable? High-quality CPR (push at least 2 inches deep, 100-120 compressions/min, full recoil, minimal interruptions) underlies every pathway.
Shockable rhythms - ventricular fibrillation (VF) and pulseless ventricular tachycardia (pVT):
- Defibrillate immediately - 200 J biphasic (or device-specific; 360 J monophasic). Resume CPR right away for 2 minutes; do not pause to check a pulse after the shock.
- After the second shock, give epinephrine 1 mg IV/IO every 3-5 minutes.
- After the third shock, give amiodarone 300 mg IV/IO (second dose 150 mg), or lidocaine as an alternative.
Non-shockable rhythms - asystole and pulseless electrical activity (PEA):
- Do not defibrillate. Provide continuous high-quality CPR and give epinephrine 1 mg every 3-5 minutes as early as possible.
- Aggressively search for and treat reversible causes.
Reversible Causes: The Hs and Ts
For PEA and asystole especially, identifying a reversible cause is the difference between return of spontaneous circulation and a failed code.
| The Hs | The Ts |
|---|---|
| Hypovolemia | Tension pneumothorax |
| Hypoxia | Tamponade (cardiac) |
| Hydrogen ion (acidosis) | Toxins |
| Hypo-/hyperkalemia | Thrombosis, pulmonary (PE) |
| Hypothermia | Thrombosis, coronary (MI) |
For example, PEA in a dialysis patient suggests hyperkalemia - give calcium, insulin/dextrose, and bicarbonate. PEA with distended neck veins and tracheal deviation suggests a tension pneumothorax needing needle decompression. PEA after chest trauma with muffled heart sounds suggests tamponade needing pericardiocentesis. These cause-specific reversals are favorite CEN distractor sets.
Tachycardia and Bradycardia With a Pulse
Tachycardia (rate > 150) with a pulse: the first question is stability. Signs of instability are hypotension, acutely altered mental status, signs of shock, ischemic chest discomfort, or acute heart failure.
- Unstable + tachycardia: perform synchronized cardioversion.
- Stable narrow-complex regular (SVT): try vagal maneuvers first (Valsalva, carotid sinus massage), then adenosine 6 mg rapid IV push with a fast saline flush; if no conversion, give 12 mg. Adenosine briefly stops the heart and patients feel a frightening pause.
- Atrial fibrillation/flutter with rapid ventricular response: rate control with a calcium channel blocker (diltiazem) or beta-blocker if stable; cardiovert if unstable.
Symptomatic bradycardia: give atropine 1 mg IV (per the 2020 AHA update, increased from 0.5 mg), repeated every 3-5 minutes to a maximum of 3 mg. If atropine fails, start transcutaneous pacing or a dopamine (5-20 mcg/kg/min) or epinephrine (2-10 mcg/min) infusion. Atropine is less effective in high-degree (Mobitz II or third-degree) block, where pacing is the priority.
Reading the Strips: Rhythm Recognition
The CEN shows rhythm strips and expects rapid identification because the rhythm dictates the algorithm. Anchor your recognition on a few discriminators:
- Ventricular fibrillation: chaotic, irregular, no identifiable QRS - defibrillate.
- Ventricular tachycardia: wide, regular, fast QRS complexes; pulseless VT is defibrillated, while VT with a pulse follows the tachycardia algorithm.
- Asystole: a flat line - confirm in two leads and check lead/connection before calling it; never shock asystole.
- PEA: an organized rhythm on the monitor with no palpable pulse - the monitor lies, the patient is in arrest.
- Atrial fibrillation: irregularly irregular, no discernible P waves.
- Atrial flutter: sawtooth flutter waves, often a regular ventricular response.
- First-, second- (Mobitz I/II), and third-degree AV block: distinguished by the PR interval and the relationship of P waves to QRS complexes.
A tested trap is confusing fine VF with asystole; if in doubt about a flat-looking rhythm, confirm leads and consider it shockable VF rather than withholding defibrillation.
Post-Cardiac-Arrest Care
After return of spontaneous circulation (ROSC), the work is not over. The CEN tests the post-arrest bundle:
- Optimize oxygenation and ventilation: titrate to an SpO2 of 92-98% and a normal end-tidal CO2; avoid hyperoxia and hyperventilation.
- Support hemodynamics: treat hypotension (SBP < 90) with fluids and vasopressors to maintain perfusion.
- Obtain a 12-lead ECG: if STEMI is present, emergent coronary angiography is indicated.
- Targeted temperature management (TTM): for comatose patients, controlled temperature support improves neurologic outcomes.
- Identify and treat the underlying cause (the Hs and Ts) that precipitated the arrest.
These post-ROSC priorities frequently appear as "what is the next step" questions after a successful resuscitation.
Defibrillation versus cardioversion
A classic CEN distinction is defibrillation versus synchronized cardioversion. Defibrillation delivers an unsynchronized shock at full energy and is used for pulseless rhythms (VF and pulseless VT) - there is no organized QRS to synchronize to. Synchronized cardioversion times the shock to the R wave to avoid the vulnerable T-wave period (the R-on-T phenomenon that can induce VF) and is used for unstable tachycardias with a pulse (unstable SVT, atrial fibrillation/flutter, or VT with a pulse).
Pressing "sync" on a pulseless patient wastes time because the machine waits for a QRS that will not come; conversely, defibrillating a perfusing rhythm can provoke VF. Knowing which mode applies to which rhythm is a frequently tested decision point in this domain. A related caveat: polymorphic VT (torsades de pointes) in a pulseless patient is treated like VF with unsynchronized high-energy shocks, because the irregular, varying QRS morphology prevents reliable synchronization - and torsades specifically is treated with IV magnesium sulfate in addition to defibrillation when associated with a prolonged QT interval.
A patient in pulseless ventricular tachycardia has received two shocks, epinephrine, and ongoing CPR. After the third shock, which medication is indicated next?
A stable patient presents with a regular narrow-complex tachycardia at 180/min. After vagal maneuvers fail, what is the appropriate next intervention?
A dialysis patient is found in PEA. Which reversible cause should the team suspect first?
Per current AHA guidance, what is the recommended atropine dose for symptomatic bradycardia?